Published in Horm Mol Biol Clin Investig on December 01, 2010
Progesterone in Breast Cancer Angiogenesis. SM J Reprod Health Infertil (2015) 0.80
Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling. Front Endocrinol (Lausanne) (2015) 0.77
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J Am Coll Cardiol (2013) 2.87
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation (2002) 2.18
Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res (2004) 1.84
Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A (2006) 1.79
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J (2008) 1.66
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Non-genomic actions of sex steroid hormones. Eur J Endocrinol (2003) 1.48
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause (2007) 1.47
Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest (2002) 1.40
Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35
Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS One (2008) 1.14
Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol (2010) 1.12
Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation (2002) 1.11
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod (2007) 1.08
Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One (2008) 1.08
Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol (2008) 1.08
Kallmann syndrome in women: from genes to diagnosis and treatment. Gynecol Endocrinol (2013) 1.02
Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas (2008) 1.00
Extra-nuclear signaling of estrogen receptors. IUBMB Life (2008) 0.98
Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids (2002) 0.98
Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer (2010) 0.97
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology (2003) 0.97
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology (2004) 0.96
Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton. Steroids (2008) 0.96
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab (2008) 0.95
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril (2008) 0.95
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One (2012) 0.95
Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Mol Endocrinol (2009) 0.95
Increased spontaneous eye blink rate following prolonged wakefulness. Physiol Behav (2006) 0.92
Lateral thinking, from the Hopfield model to cortical dynamics. Brain Res (2011) 0.92
Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod (2008) 0.90
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. Cell Cycle (2012) 0.89
EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy. Maturitas (2012) 0.89
Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy. Cancer (2006) 0.88
EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women. Maturitas (2013) 0.88
Antimicrobial activity of the ornamental species Salvia corrugata, a potential new crop for extractive purposes. J Agric Food Chem (2008) 0.88
Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF. J Assist Reprod Genet (2008) 0.88
P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res (2006) 0.87
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas (2003) 0.87
Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC Cancer (2008) 0.87
Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J Agric Food Chem (2008) 0.87
Oestrogen and progestins differently prevent glutamate toxicity in cortical neurons depending on prior hormonal exposure via the induction of neural nitric oxide synthase. Steroids (2009) 0.86
Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol (2009) 0.86
Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol (2010) 0.86
17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release. Mol Hum Reprod (2012) 0.85
[Extending hemicelluloses content calibration of Acacia spp using NIR to new sites]. Guang Pu Xue Yu Guang Pu Fen Xi (2010) 0.85
Estrogen regulates endometrial cell cytoskeletal remodeling and motility via focal adhesion kinase. Fertil Steril (2010) 0.85
Why sex matters: the biological mechanisms of cardiovascular disease. Gynecol Endocrinol (2012) 0.84
Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology (2002) 0.84
Timing is everything. Gynecol Endocrinol (2007) 0.84
Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes. Leuk Res (2005) 0.84
Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia. Ann Hematol (2007) 0.84
A functioning FSH-secreting pituitary macroadenoma causing an ovarian hyperstimulation syndrome with multiple cysts resected and relapsed after leuprolide in a reproductive-aged woman. Gynecol Endocrinol (2011) 0.83
Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase. J Cell Mol Med (2012) 0.83
Pregnancy complications in polycystic ovary syndrome patients. Gynecol Endocrinol (2014) 0.83
Are risk factors common to thyroid cancer and nodule? A forty years observational time-trend study. PLoS One (2012) 0.83
Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging (2007) 0.83
Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest (2002) 0.83
Characterizing the complexity of brain and mind networks. Philos Trans A Math Phys Eng Sci (2011) 0.83
Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril (2003) 0.83
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas (2006) 0.82
Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton. J Cell Mol Med (2009) 0.82
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecol Endocrinol (2014) 0.82
Non-genomic sex steroid actions in the vascular system. Semin Reprod Med (2007) 0.82
Intracardiac echocardiogram-guided use of a Dormia basket to prevent major vegetation embolism during transvenous lead extraction. Can J Cardiol (2013) 0.82
Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats. J Nutr Biochem (2012) 0.81
Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas (2005) 0.81
Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol (2002) 0.81
Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib. Haematologica (2004) 0.81
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol (2012) 0.81
Effects of oral contraceptives on bone mineral density. Treat Endocrinol (2004) 0.81
The metabolic syndrome and its components in postmenopausal women. Gynecol Endocrinol (2013) 0.80
Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther (2003) 0.80
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord (2003) 0.80
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan. Cancer Biother Radiopharm (2013) 0.80
Estrogen receptor-{alpha} promotes endothelial cell motility through focal adhesion kinase. Mol Hum Reprod (2010) 0.80
Membrane integrity evaluation in rabbit spermatozoa. Eur J Obstet Gynecol Reprod Biol (2002) 0.80
Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause (2008) 0.80
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol (2006) 0.80
Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause (2005) 0.80
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma. Leuk Res (2007) 0.80
Outcome of Patients Treated by Cardiac Resynchronization Therapy Using a Quadripolar Left Ventricular Lead. Circ J (2016) 0.80
The female pelvic floor through midlife and aging. Maturitas (2013) 0.79
Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med (2012) 0.79
Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas (2012) 0.79